Basic HTML Version
112
SCIENTIFIC REPORT 2012
Title:
Descriptive analysis of psychopathological variables, intelligence, personality and
psychobiographical, identified in adolescents with school rejection admitted to a
Mental Health hospitalization unit.
District Attorney:
Own.
Principal Investigator:
Rebeca Gracia Liso.
Title:
Registration of patients with multiple sclerosis (MS) treated with Natalizumab in Spain.
District Attorney:
Spanish Academy of Multiple Sclerosis (ACADEM).
Principal Investigator:
Miguel Marco Same.
Title:
Observational, cross - sectional, multicenter, national study to evaluate the
burden that Recurrent Multiple Sclerosis produces in patients and their
caregivers. MSFeeling study.
District Attorney:
Novartis Farmacéutica SA
Principal Investigator:
Miguel Marco Same.
Title:
Open-label safety and tolerability study of Memantine in pediatric patients with
autism, Asperger’s syndrome or generalized unspecified developmental disorder (TGD-
NE).
District Attorney:
Forest Research Institute, Inc.
Principal Investigator:
Montserrat Pamias Massana.
Title:
Double-blind, placebo-controlled, randomized, safety and efficacy study
Memantine withdrawal in pediatric patients with autism, Asperger's syndrome or disorder
generalized unspecified developmental (TGD-NE) previously treated with Memantine.
District Attorney:
Forest Research Institute, Inc.
Principal Investigator:
Montserrat Pamias Massana.
Title:
Open-label study of the safety and tolerability of Memantine in patients
pediatric patients with autism, Asperger's syndrome or generalized developmental disorder no
specified (TGD-NE).
District Attorney:
Forest Research Institute, Inc.
Principal Investigator:
Montserrat Pamias Massana.
Title:
Effectiveness of Meta-Cognitive Training (EMC) on symptoms, metacognition,
social and neuropsychological functioning in people with short-lived psychosis.
District Attorney:
External FIS.
Principal Investigator:
Esther Pousas Tomás.